Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 26Unknown 5Terminated 3Not yet recruiting 3Withdrawn 2Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Pancreatic Neoplasms 2Pancreatic Adenocarcinoma 1

Interventions

Drug Therapy 107Cisplatin 97Radiotherapy 89Carboplatin 87Bevacizumab 79Oxaliplatin 74tislelizumab 68Capecitabine 67Cyclophosphamide 65Gemcitabine 64toripalimab 61Paclitaxel 57Specimen Handling 55pembrolizumab 54sintilimab 53Surgical Procedures, Operative 52anlotinib 49Magnetic Resonance Spectroscopy 49Fluorouracil 49Immune Checkpoint Inhibitors 43Blood Specimen Collection 42130-nm albumin-bound paclitaxel 42Standard of Care 39camrelizumab 36fludarabine 35lenvatinib 34Leucovorin 34venetoclax 30Radiosurgery 30Immunotherapy 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × Pancreaticoduodenectomy × Clear all
NCT07547033 2026-04-23

EQUINOXE

Assistance Publique - Hôpitaux de Paris

Phase NA Not yet recruiting
150 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

NCT06703905 2024-11-25

Conventional Partial Pancreatoduodenectomy Versus an Extended Pancreatoduodenectomy for Pancreatic Head Cancers

First Affiliated Hospital Xi'an Jiaotong University

Phase NA Not yet recruiting
270 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT04847297 2021-04-19

PEAR

University of Pecs

Not yet recruiting
353 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡